MRPL48 is a novel prognostic and predictive biomarker of hepatocellular carcinoma

被引:0
作者
Yu-Xiang Lin
Jun-Yong Pan
Wen-Du Feng
Tian-Cong Huang
Cheng-Zong Li
机构
[1] The Second Affiliated Hospital of Fujian Medical University (Donghai District),Department of Hepatobiliary and Pancreatic Surgery
[2] The Second Affiliated Hospital of Fujian Medical University,Central Supply Service Department
来源
European Journal of Medical Research | / 28卷
关键词
Hepatocellular carcinoma; MRPL48; Prognostic value; Biomarker; Biological functions;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Value of KPNA4 as a diagnostic and prognostic biomarker for hepatocellular carcinoma
    Xu, Mingxing
    Liang, Hao
    Li, Kun
    Zhu, Shu
    Yao, Zhicheng
    Xu, Ruiyun
    Lin, Nan
    AGING-US, 2021, 13 (04): : 5263 - 5283
  • [42] CTHRC1 May Serve As A Prognostic Biomarker For Hepatocellular Carcinoma
    Zhou, Huifang
    Su, Libo
    Liu, Chao
    Li, Baosheng
    Li, Hui
    Xie, Ying
    Sun, Dianxing
    ONCOTARGETS AND THERAPY, 2019, 12 : 7823 - 7831
  • [43] Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
    Ao, Junjie
    Chiba, Tetsuhiro
    Kanzaki, Hiroaki
    Kanayama, Kengo
    Shibata, Shuhei
    Kurosugi, Akane
    Iwanaga, Terunao
    Kan, Motoyasu
    Sakuma, Takafumi
    Qiang, Na
    Ma, Yaojia
    Kojima, Ryuta
    Kusakabe, Yuko
    Nakamura, Masato
    Kobayashi, Kazufumi
    Kiyono, Soichiro
    Kanogawa, Naoya
    Saito, Tomoko
    Nakagawa, Ryo
    Kondo, Takayuki
    Ogasawara, Sadahisa
    Suzuki, Eiichiro
    Nakamoto, Shingo
    Muroyama, Ryosuke
    Tawada, Akinobu
    Kato, Jun
    Kanda, Tatsuo
    Maruyama, Hitoshi
    Kato, Naoya
    JOURNAL OF CANCER, 2021, 12 (09): : 2694 - 2701
  • [44] NIFK, an independent prognostic biomarker of hepatocellular carcinoma, is correlated with immune infiltration
    Cheng, Fei
    Yuan, Lebin
    Wu, Zhao
    Li, Huizi
    Shen, Wei
    ELECTRONIC JOURNAL OF BIOTECHNOLOGY, 2023, 63 : 30 - 40
  • [45] Alpha-fetoprotein: A controversial prognostic biomarker for small hepatocellular carcinoma
    Asrih, Mohamed
    Lenglet, Sebastien
    Mach, Francois
    Montecucco, Fabrizio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (03) : 328 - 330
  • [46] Biomarker in Hepatocellular Carcinoma
    Basthi Mohan, Pooja
    Lochan, Rajiv
    Shetty, Shiran
    INDIAN JOURNAL OF SURGICAL ONCOLOGY, 2024, 15 (SUPPL 2) : 261 - 268
  • [47] Phosphogluconate dehydrogenase is a predictive biomarker for immunotherapy in hepatocellular carcinoma
    Liu, Tiantian
    Qi, Jianni
    Wu, Hao
    Wang, Le
    Zhu, Lihui
    Qin, Chengyong
    Zhang, Jiao
    Zhu, Qiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
    Amira Isaac
    Sherif Mounir Mohamed
    Osama Ashraf Ahmed
    Ahmed Gamal Mohamed Hassan
    Hany Samir Rasmy
    The Egyptian Journal of Internal Medicine, 2021, 33
  • [49] Amphiregulin as a novel diagnostic and prognostic biomarker of hepatocellular carcinoma before and after locoregional treatment
    Isaac, Amira
    Mohamed, Sherif Mounir
    Ahmed, Osama Ashraf
    Hassan, Ahmed Gamal Mohamed
    Rasmy, Hany Samir
    EGYPTIAN JOURNAL OF INTERNAL MEDICINE, 2021, 33 (01)
  • [50] Centromere Protein F (CENPF) Serves as a Potential Prognostic Biomarker and Target for Human Hepatocellular Carcinoma
    Huang, Yugang
    Chen, Xiuwen
    Wang, Li
    Wang, Tieyan
    Tang, Xianbin
    Su, Xiaomin
    JOURNAL OF CANCER, 2021, 12 (10): : 2933 - 2951